Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 29, 2016 10:30 ET | Source: TetraLogic Pharmaceuticals

TetraLogic Pharmaceuticals Corporation Announces Completion of Sale of SMAC Mimetic and HDAC Inhibitor Assets to Medivir AB

PAOLI, Pa., Dec. 29, 2016 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) (“TetraLogic” or “Company”) and its wholly-owned subsidiary TetraLogic Research and Development...
November 02, 2016 16:30 ET | Source: TetraLogic Pharmaceuticals

TetraLogic Announces Agreements to Sell SMAC mimetic and HDAC inhibitor assets to Medivir and to Restructure its Convertible Senior Notes and Delisting of Common Stock

PAOLI, Pa., Nov. 02, 2016 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) (“TetraLogic” or “Company”), a clinical-stage biopharmaceutical company focused on discovering and...
January 06, 2016 16:10 ET | Source: TetraLogic Pharmaceuticals

TetraLogic Pharmaceuticals Announces Data on Lead Clinical Programs

Birinapant Shows No Activity in Randomized Phase 2 MDS Study SHAPE Shows Clinical Benefit in Randomized Phase 2 CTCL Study MALVERN, Pa., Jan. 06, 2016 (GLOBE NEWSWIRE) -- TetraLogic...
November 09, 2015 07:00 ET | Source: TetraLogic Pharmaceuticals

TetraLogic Pharmaceuticals Announces Clinical Data on Birinapant to be Presented at the 57th Annual American Society of Hematology Annual Meeting

MALVERN, Pa., Nov. 9, 2015 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG) today announced that two abstracts discussing clinical data on birinapant will be presented at the...
November 04, 2015 16:01 ET | Source: TetraLogic Pharmaceuticals

TetraLogic Reports Third Quarter Financial Results and Provides Clinical Programs Update

MALVERN, Pa., Nov. 4, 2015 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG), a clinical-stage biopharmaceutical company focused on discovering and developing novel small...
November 02, 2015 07:00 ET | Source: TetraLogic Pharmaceuticals

TetraLogic Announces the Opening of an IND for SHAPE Gel in Alopecia Areata

MALVERN, Pa., Nov. 2, 2015 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG) today announced that it has an open U.S. Investigational New Drug application in support of a Phase...
August 05, 2015 16:01 ET | Source: TetraLogic Pharmaceuticals

TetraLogic Reports Second Quarter Financial Results and Provides Clinical Programs Update

MALVERN, Pa., Aug. 5, 2015 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG), a clinical-stage biopharmaceutical company focused on discovering and developing novel small...
July 29, 2015 07:31 ET | Source: TetraLogic Pharmaceuticals

TetraLogic to Present at the Jefferies 2015 Hepatitis B Summit

MALVERN, Pa., July 29, 2015 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) today announced that the Company will present at the Jefferies 2015 Hepatitis B Summit on Thursday,...
July 20, 2015 16:02 ET | Source: TetraLogic Pharmaceuticals

TetraLogic Provides Update on Hepatitis B Clinical Program

MALVERN, Pa., July 20, 2015 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) a clinical-stage biopharmaceutical company focuses on discovering and developing novel small...
June 30, 2015 16:01 ET | Source: TetraLogic Pharmaceuticals

TetraLogic Announces Update on MDS Clinical Program

MALVERN, Pa., June 30, 2015 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG), a clinical-stage biopharmaceutical company focused on discovering and developing novel small...

Next Page keyboard_arrow_right